EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential

Fengguang Yang iD, Jinglin Ma, Daxue Zhu, Zhaoheng Wang, Yanhu Li, Xuegang He, Guangzhi Zhang iD, Xuewen Kang

Biomolecules · 2023

DOI: 10.3390/biom13071139 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Fengguang Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China. Hauptthemen laut MEDLINE: Liver Neoplasms, S100 Calcium Binding Protein A6. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Gansu Province, China, University Innovation Fund Project of Gansu Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

S100A6, also known as calcyclin, is a low-molecular-weight Ca2+-binding protein from the S100 family that contains two EF-hands. S100A6 is expressed in a variety of mammalian cells and tissues. It is also expressed in lung, colorectal, pancreatic, and liver cancers, as well as other cancers such as melanoma. S100A6 has many molecular functions related to cell proliferation, the cell cycle, cell differentiation, and the cytoskeleton. It is not only involved in tumor invasion, proliferation, and migration, but also the pathogenesis of other non-neoplastic diseases. In this review, we focus on the molecular mechanisms and potential therapeutic targets of S100A6 in tumors, nervous system diseases, leukemia, endometriosis, cardiovascular disease, osteoarthritis, and other related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsS100 Calcium Binding Protein A6AnimalsFemaleHumansCell CycleCell Cycle ProteinsCell DifferentiationCell ProliferationMammalsS100 Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseS100A6endometriosisleukemiamyocardial infarctiontumor

Substanzen

Cell Cycle ProteinsS100 Calcium Binding Protein A6S100 ProteinsS100A6 protein, human

Autor:innen und Institutionen

  • Department of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.
  • The Second Clinical Medical College, Lanzhou University, Lanzhou 730030, China.
  • Orthopaedics Key Laboratory of Gansu Province, Lanzhou University Second Hospital, Lanzhou 730030, China.
  • School of Petrochemical Engineering, Lanzhou University of Technology, Lanzhou 730050, China.

ORCID-Profile: Fengguang Yang, Guangzhi Zhang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Gansu Province, China
  • University Innovation Fund Project of Gansu Provincial Department of Education
  • Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital
  • Cuiying Student Research and Cultivation Project of Lanzhou University Second Hospital

Zitieren

APA

Yang, F., Ma, J., Zhu, D., Wang, Z., Li, Y., He, X., Zhang, G., & Kang, X. (2023). The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. Biomolecules. https://doi.org/10.3390/biom13071139

Vancouver

Yang F, Ma J, Zhu D, Wang Z, Li Y, He X, et al. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. Biomolecules. 2023. doi:10.3390/biom13071139

BibTeX
@article{Yang2023,
  author = {Yang, Fengguang and Ma, Jinglin and Zhu, Daxue and Wang, Zhaoheng and Li, Yanhu and He, Xuegang and Zhang, Guangzhi and Kang, Xuewen},
  title = {The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13071139}
}
Kostenlos starten →